Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial. (Q42248109)
Jump to navigation
Jump to search
scientific article published on 11 September 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial. |
scientific article published on 11 September 2013 |
Statements
Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial (English)
C Lemanski
A Levy
A Delarochefordiere
I Martel-Lafay
E Rio
D Malka
T Conroy
L Miglianico
Y Becouarn
K Malekzadeh
E Paris
B Juzyna
P Ezra
11 September 2013